Primary and Secondary Prevention of CAD: A Review

Short, Lindsay; La, Van T.; Patel, Mandira; Pai, Ramdas G.

doi:10.1055/s-0041-1729925

Cited by 4 publications

(3 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A crucial aspect of the secondary prevention of CAD involves effectively managing the modifiable risk factors that influence the progression and recurrence of the condition. In this context, evidence-based guidelines and treatment protocols have been established to provide healthcare professionals with more precise targets and therapeutic options [ 17 ]. Pharmaceutical developments have led to the introduction of novel lipid-lowering treatments, such as PCSK9 approaches and mixed treatments, which have revealed considerable efficiency in accomplishing reduced LDL cholesterol levels alongside conventional statin treatment.…”

Section: Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Updates in the Management of Coronary Artery Disease: A Review Article

Bansal,

Hiwale

2023

Cureus

View full text Add to dashboard Cite

Coronary artery disease (CAD) remains a significant health challenge, imposing substantial burdens on individuals and healthcare systems worldwide. CAD's impact stems from artery narrowing and blockage, leading to severe complications like heart attacks and heart failure. Collaborative efforts by researchers, professionals, and governments have fostered advancements in comprehending and managing this cardiovascular ailment. Evolving CAD management embraces modern diagnostics, cutting-edge pharmaceuticals, invasive procedures, lifestyle modifications, and cardiac rehabilitation. This comprehensive approach aims to amplify outcomes and elevate the quality of life for CAD-affected individuals. This review delves into innovative treatments, pivotal breakthroughs, and recent trends in clinical practices that collectively shape CAD management. The exploration encompasses novel diagnostic technologies enabling early detection and risk assessment. Moreover, it investigates recent breakthroughs in medications that profoundly impact platelet disorders, lipid reduction, and angina. Precision medicine's role in tailoring treatment strategies based on patient characteristics is thoroughly examined. Advances in invasive procedures, like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), have revolutionised coronary revascularisation, substantially improved long-term outcomes, and reduced restenosis rates. The increasing significance of lifestyle changes and cardiac rehabilitation in CAD management, augmenting treatment options and patient recovery, are meticulously scrutinized. While these strides are pivotal, research continues to chart new paths in CAD management, from innovative drugs to collaborative multidisciplinary care models. Staying attuned to the latest advancements and embracing a patient-centric approach can collectively reduce CAD's impact and facilitate the lives of those grappling with this chronic cardiovascular disorder.

show abstract

Section: Reviewmentioning

confidence: 99%

“…Short et al [17] 2021 USA CVD causes global health problems, but lifestyle changes and medication offer opportunities to help millions. Despite medical progress, two-thirds of patients do not follow treatment, even in secondary prevention.…”

Section: Giuliano Et Al [16] 2017 Australiamentioning

confidence: 99%

Updates in the Management of Coronary Artery Disease: A Review Article

Bansal,

Hiwale

2023

Cureus

View full text Add to dashboard Cite

show abstract

“…Chronic diseases require medication management and the improvement of healthy habits throughout life after an emergence, and long-term healthcare and preventive activities are essential. Coronary artery disease (CAD), which accounts for the largest proportion of heart diseases, requires careful health management because of its high risk of recurrence (even after acute treatment), rapid changes in symptoms, and high risk of emergency hospitalization [ 2 , 3 ]. In particular, the absence of health-related behavior practices of CAD patients affect not only the deterioration and recurrence of the disease, but also readmission and associated mortality [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

Health information-seeking behavior in patients with coronary artery disease: Activating methods

Kim,

Kim

2024

PLoS ONE

View full text Add to dashboard Cite

Introduction Coronary artery disease (CAD) has a high mortality rate worldwide, and continuous health behavior practice and careful management are required owing to risks such as rapid changes in symptoms and emergency hospitalization. The utilization of health-related information is an important factor for long-term disease management in patients with CAD. For this purpose, an understanding of health information-seeking behavior is needed first. Methods This study analyzed data from the 2021 Korea Medical Panel Survey, and logistic regression analysis was conducted to confirm the factors influencing the health information-seeking behavior of patients with CAD. Results The health information-seeking behavior of patients with CAD differed according to demographic characteristics, and differences in preferred information use were confirmed. Finally, it was identified that insufficient levels of health literacy were a major reason for CAD patients not engaging in health information-seeking behaviors (OR, 0.17; 95% CI, 0.09–0.33; p < 0.001). Conclusion This study suggests that to improve health information-seeking behaviors, the application of education and intervention programs to increase the level of health literacy is necessary.

show abstract